Literature DB >> 25588986

A bright future for Hormones and Cancer: farewell comments of Dr. Carol A. Lange, recent past Editor-in-Chief.

Carol A Lange1.   

Abstract

Mesh：

Year:  2015        PMID： 25588986     DOI： 10.1007/s12672-014-0212-z

Source DB:  PubMed          Journal:  Horm Cancer        ISSN： 1868-8497            Impact factor:   3.869


× No keyword cloud information.
  3 in total

1.  AR collaborates with ERα in aromatase inhibitor-resistant breast cancer.

Authors:  Yassine Rechoum; Daniela Rovito; Domenico Iacopetta; Ines Barone; Sebastiano Andò; Nancy L Weigel; Bert W O'Malley; Powel H Brown; Suzanne A W Fuqua
Journal:  Breast Cancer Res Treat       Date:  2014-09-02       Impact factor: 4.872

2.  Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.

Authors:  Yangsik Jeong; Yang Xie; Guanghua Xiao; Carmen Behrens; Luc Girard; Ignacio I Wistuba; John D Minna; David J Mangelsdorf
Journal:  PLoS Med       Date:  2010-12-14       Impact factor: 11.069

3.  Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Authors:  A R Daniel; A L Gaviglio; T P Knutson; J H Ostrander; A B D'Assoro; P Ravindranathan; Y Peng; G V Raj; D Yee; C A Lange
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.